Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

DRG International, Inc.

DRG International, a global innovator of high-quality medical diagnostics and equipment, provides the medical and res... read more Featured Products: More products

Download Mobile App





Diagnostic Test that Measures Active Renin in Hypertension Displayed at the 2015 AACC Annual Meeting

By LabMedica International staff writers
Posted on 28 Jul 2015
A new ELISA test that measures levels of active renin in human EDTA plasma has been available for inspection at Booth 819 at the 2015 AACC Annual Meeting & Clinical Lab Expo (Atlanta, GA, USA).

Measurement of levels of active renin in the blood is useful for diagnosing certain types of hypertension. More...
DRG International (Springfield, NJ, USA) has produced a solid phase "sandwich" ELISA kit that is accurate in the range of 0.8 to 128 picograms per milliliter. The assay uses 50 microliters of EDTA plasma and requires about 3 hours and 15 minutes to perform.

The DRG Renin (Active) ELISA Kit can also effectively detect hypertension in pregnancy. Early discovery of hypertension in the expectant mother opens up a much more effective array of treatment methods for the patient.

“The DRG Renin (Active) ELISA Kit allows research laboratories to quickly and easily measure for renin,” said Dr. Cyril E. Geacintov, founder, president, and CEO of DRG International. “The accuracy of our test has made it the top choice of researchers in the field and its applications continue to grow.”

Related Links:

2015 AACC Annual Meeting & Clinical Lab Expo
DRG International



New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Gold Member
Rapid AKI Test
Acute Kidney Injury (AKI) Array (4-plex)
New
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.